Left atrial shape as a marker of atrial myopathy in embolic stroke of undetermined source.

echocardiography left atrial function left atrial myopathy left atrial shape left atrial sphericity left atrial strain left atrium

Journal

European heart journal. Cardiovascular Imaging
ISSN: 2047-2412
Titre abrégé: Eur Heart J Cardiovasc Imaging
Pays: England
ID NLM: 101573788

Informations de publication

Date de publication:
15 Mar 2024
Historique:
received: 01 01 2024
revised: 03 03 2024
accepted: 08 03 2024
medline: 15 3 2024
pubmed: 15 3 2024
entrez: 15 3 2024
Statut: aheadofprint

Résumé

Embolic Stroke of Undetermined Source (ESUS) results in significant morbidity. A left atrial (LA) myopathy is implicated in a proportion of these patients. We hypothesized that LA shape varies by cause of stroke (cardioembolic versus ESUS). 236 ischemic stroke, atrial fibrillation (AF) patients and controls were recruited prospectively. AF was classified as paroxysmal (PAF) or persistent AF (PersAF). Stroke patients comprised cardioembolic stroke (CE) secondary to AF and ESUS. There were 81 AF (47 PAF, 34 PersAF), 50 ESUS, 57 CE patients (subdivided into CE with PAF (CEpaf) and CE with PersAF (CEpers) and 48 controls. Echocardiographic parameters including LA volume, function, and shape/sphericity (3D LA-sphericity and 2D-derived LA-circularity, ellipticity, sphericity and eccentricity indices) were evaluated. Increased LA volume and sphericity with LA dysfunction was present in CE, AF and ESUS groups compared to controls. K-means cluster analysis demonstrated a spectrum of LA myopathy with controls at the lowest and CEpers and PersAF at the upper extremes, with ESUS, PAF and CEpaf being similar and falling between these extremes. After adjusting for age, sex and left ventricular (LV) and LA parameters, LA sphericity markers differentiated ESUS from controls (p < 0.01). Alterations in LA shape are present in ESUS, AF and CE patients, particularly increased spherical remodelling. The novel markers of LA sphericity proposed may identify LA myopathy in ESUS patients and potentially guide management for secondary prevention.

Identifiants

pubmed: 38487870
pii: 7629466
doi: 10.1093/ehjci/jeae078
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

© The Author(s) 2024. Published by Oxford University Press on behalf of the European Society of Cardiology. All rights reserved. For commercial re-use, please contact reprints@oup.com for reprints and translation rights for reprints. All other permissions can be obtained through our RightsLink service via the Permissions link on the article page on our site—for further information please contact journals.permissions@oup.com.

Auteurs

Aaisha Ferkh (A)

Westmead Clinical School, University of Sydney, Westmead NSW, Australia.
Cardiology Department, Westmead Hospital, Westmead NSW, Australia.

Kasun De Silva (K)

Westmead Clinical School, University of Sydney, Westmead NSW, Australia.
Cardiology Department, Westmead Hospital, Westmead NSW, Australia.

Jennifer Pham (J)

Cardiology Department, Westmead Hospital, Westmead NSW, Australia.

Luke Stefani (L)

Westmead Clinical School, University of Sydney, Westmead NSW, Australia.
Cardiology Department, Westmead Hospital, Westmead NSW, Australia.

Karen Byth (K)

WSLHD Research and Education Network, Westmead Hospital NSW, Australia.

Amy Clark (A)

Westmead Clinical School, University of Sydney, Westmead NSW, Australia.
Cardiology Department, Westmead Hospital, Westmead NSW, Australia.

Siddharth J Trivedi (SJ)

Westmead Clinical School, University of Sydney, Westmead NSW, Australia.
Cardiology Department, Westmead Hospital, Westmead NSW, Australia.

Sai Nagaratnam (S)

Neurology Department, Westmead Hospital, Westmead NSW, Australia.

Andrew Duggins (A)

Westmead Clinical School, University of Sydney, Westmead NSW, Australia.
Neurology Department, Westmead Hospital, Westmead NSW, Australia.

Eddy Kizana (E)

Westmead Clinical School, University of Sydney, Westmead NSW, Australia.
Cardiology Department, Westmead Hospital, Westmead NSW, Australia.
Centre for Heart Research, The Westmead Institute for Medical Research.

Aravinda Thiagalingam (A)

Westmead Clinical School, University of Sydney, Westmead NSW, Australia.
Cardiology Department, Westmead Hospital, Westmead NSW, Australia.

Liza Thomas (L)

Westmead Clinical School, University of Sydney, Westmead NSW, Australia.
Cardiology Department, Westmead Hospital, Westmead NSW, Australia.
South-West Clinical School, University of New South Wales, Liverpool NSW, Australia.

Classifications MeSH